Atlas Trials

Enoxaparin for Primary Thromboprophylaxis in Ambulatory Patients With COVID-19

Clinical trial NCT04400799 · TERMINATED

Trial details

NCT number
NCT04400799
Sponsor
University of Zurich
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
COVID-19Pulmonary Embolism, Deep Vein Thrombosis
Start date
2020-06-15
Primary completion
2022-02-07
Enrollment
475

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.